insights_auto
Why is EYPT down 2,45%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
3,15 USD
arrow_downward
-2,45%(-0,079) 1D
2-окт., 10:04:53 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,31 USD
High
3,31 USD
Low
3,10 USD
Mkt. cap
271,65 млн
Avg. vol.
3,95 млн
Volume
207,08 миң
52-wk high
19,01 USD
52-wk low
3,10 USD
EPS
-3,74 USD
Beta
1,67
Shares outstanding
86,21 млн
No. of employees
214
Open
3,31 USD
High
3,31 USD
Low
3,10 USD
Mkt. cap
271,65 млн
Avg. vol.
3,95 млн
Volume
207,08 миң
52-wk high
19,01 USD
52-wk low
3,10 USD
EPS
-3,74 USD
Beta
1,67
Shares outstanding
86,21 млн
No. of employees
214
News stories
From web sources and news partners
CNBC
·
30 мүнөт мурун
New York Giants Football rings the Opening Bell at the NYSE
GlobeNewswire
·
1 саат мурун
ATA Creativity Global Announces Receipt of a Bid Deficiency Notice from Nasdaq
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersУотертаун, Массачусетс, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio